Loading...
XSHE
000661
Market cap3.96bUSD
Jul 10, Last price  
69.50CNY
1D
5.48%
1Q
-19.19%
Jan 2017
-37.86%
Name

Changchun High & New Tech Industry Inc

Chart & Performance

D1W1MN
XSHE:000661 chart
P/E
182.95
P/S
2.35
EPS
0.38
Div Yield, %
3.95%
Shrs. gr., 5y
-0.33%
Rev. gr., 5y
7.10%
Revenues
12.08b
-10.27%
580,454,579662,056,599804,155,5501,023,586,7911,165,962,4101,294,589,2941,761,187,2182,048,713,4912,262,304,4482,402,089,6412,897,439,8034,102,261,5775,374,994,7087,373,701,2668,576,600,70810,746,717,26212,627,188,96614,566,039,61113,465,627,31712,083,140,489
Net income
155m
-94.00%
4,522,3667,518,08920,094,87573,154,66486,461,380109,548,646299,797,514283,885,052318,171,326384,479,507484,852,475661,948,7761,006,495,3651,775,009,2013,046,586,1493,757,472,9594,140,523,8144,532,483,5392,583,058,417154,971,452
CFO
802m
-74.16%
118,249,773211,528,771163,798,123390,330,399348,989,743169,181,491407,944,688498,580,431279,752,231770,595,142308,073,522381,387,328884,066,5721,934,670,6851,110,989,8543,330,619,2252,826,408,3335,111,442,1363,104,279,406802,133,083
Dividend
Jul 04, 20252.6 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Changchun High-Tech Industries (Group) Inc., operating with its various subsidiaries, is primarily involved in the production and distribution of biopharmaceutical products and traditional Chinese medicines across the Chinese market. Additionally, the company diversifies its activities into property development, real estate management, and leasing services. Founded in Changchun, China, in 1993, this enterprise was previously known as Changchun High & New Technology Industry (Group) Inc.
IPO date
Dec 18, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2026‑032025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT